© 2024 FineFoods
Today, according to the commitments taken under the binding term sheet signed on 16 November 2020, FINE FOODS & PHARMACEUTICALS N.T.M. S.p.A. acquired Pharmatek PMC S.r.l. entire share capital.
[button_grid]Read the press release Visit Fine Foods website[/button_grid]
Fine Foods has signed an agreement with Marchesini Group for the supply of five filling and packaging lines for the manufacturing of powdered and granular products in sachets in boxes.
The new lines, equipped with the most modern technologies, including robotics, will be installed in the Zingonia plant and will be used for the manufacturing of Food Supplements in sachets, a growing segment where Fine Foods has been market leader for a while.
Fine Foods CEO Giorgio Ferraris has declared: “We are very happy to announce this new investment that, upon completion, is expected to increase significantly our capacity, as well as our productivity.
Marchesini’s technology is already well known at Fine Foods, as we have currently twenty Marchesini lines installed in our facilities. This deal will fortify our relationship and will help us to meet the quality and volume expectations of the most demanding customers.”.
Marchesini Group’s CEO, Pietro Cassani, has declared: "We are proud, as Marchesini Group, to renew the historical relationship with Fine Foods, one of the most dynamic companies in their sector and we are certain that this operation will further strengthen our partnership”.
FINE FOODS & PHARMACEUTICALS N.T.M. S.p.A. has today signed a binding Term Sheet acquiring the entire share capital of Pharmatek PMC S.r.l.
Fine Foods & Pharmaceuticals N.T.M. S.p.A. will be attending the 16th virtual "European Midcap Event", scheduled for 23 and 24 June 2020.
The event will allow selected mid-cap companies listed on European markets to meet more than 150 institutional investors from Belgium, France, Germany, Luxembourg, the Netherlands, Spain, Switzerland and the UK.
“Fine Foods & Pharmaceuticals NTM closes 2019 with a 15% growth in revenues of 160 million and a confirmation of the adjusted margins, while the punctual ones slow down due to the costs related to the expansion of Zingonia (Food) and Brembate (Pharma), where the activities of the Nembro plant have been transferred.
Also in this 2020 characterized by the Covid-19 pandemic, the company has never stopped the production and the development of drugs and food supplements, also confirming the desire to switch to MTA after the emergency has been overcome.”
Read the full article (italian only)
Link to the article on Market Insight website (italian only)
Marco Francesco Eigenmann, President of Fine Foods & Pharmaceuticals N.T.M. S.p.A., in reference to the recent news on the outbreak of COVID-19 has commented:
“Firstly, my thoughts are with the people affected by the Coronavirus and wish them a full and speedy recovery."
Fine Foods & Pharmaceuticals N.T.M. S.p.A. will be one of the protagonist of the European Midcap Event, organized by Intermonte in Geneva from 4 to 5 December 2019. The Event is a meeting place, through one to one meeting, between European institutional investors and the Italian excellences.
A 2.000 m2 new warehouse for the storage of finished products is fully operational in the Food Supplement plant of Zingonia.
The new warehouse is climatized and can host approximately 1.800 pallets.
This new investment belongs to the substantial expansion program of the Zingonia plant, which brought the covered surface to 28.700 m2 from the existing 15.900 m2.
The US Food & Drug Administration recently audited the Zingonia Food Supplement manufacturing site of Fine Foods. No FDA 483 form was issued, meaning that no written observations were received, a further evidence of the commitment of Fine Foods to the quality of the products manufactured in its plants. The Zingonia site by the implementation of the GMPs and HACCP risk analysis, has developed a solid food safety management system certified ISO 22000 with the purpose to take under control food safety hazards. Quality System consequently ensures that Fine Foods products are in compliance with the release specifications and safe for the consumer.
Satisfaction of Fine Foods’ employees reached a new historical peak at 89.5%.
The value, is referred to employees with a tenure of three years or more and is a result of the ISO 9001 annual check. The evaluation was comprised of several criteria, such as the relationship with supervisors and colleagues, the company’s attention for the employee’s needs and appreciation for the job done.
A high score in the employee’s satisfaction results in a high stability of the staff, with an annual turnover lower than 0.5%, which guarantees a constant increase of professional skills, as well as a substantial continuity in the daily activities, both appreciated by Fine Foods’ customers.
